> Skip repeated content

Customized Coumadin Via Genetic Testing

Orthopedics This Week—September 29, 2017

Orthopedics This Week reported on a recent study that stated that genetic testing can help determine the safest dose of warfarin, a blood thinner, for patients undergoing joint replacement surgery. HSS rheumatologist Anne R. Bass, MD co-authored the study and explained that this is the first study to show that adjusting the dose based on genetic variants can make warfarin safer for patients.

Dr. Bass told OTW that "adjusting the warfarin dose without genetic variants and without a computer dosing algorithm can be tricky because different people respond to the warfarin differently, some are very sensitive and somewhat resistant. By using a dosing algorithm that can incorporate genetic variants dosing is made much less tricky."

Read the full article at ryortho.com [subscription required].

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts